After a comprehensive search of each database, 35 studies were incorporated into[7–11,13–41] this meta-analysis, including 6744 patients with NSCLC, of whom 2940 had positive expression of E-cadherin. The gene discussed is CDH1; the disease is non-small cell lung carcinoma.